| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,198 | 0,208 | 04.07. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | ARRAIL GROUP (06639): INSIDE INFORMATION - (1) DELAY IN PUBLICATION OF THE ANNUAL RESULTS FOR THE YEAR ENDED MARCH 31, 2026 AND FURTHER DELAY IN PUBLICATION ... | - | HKEx | ||
| ARRAIL GROUP Aktie jetzt für 0€ handeln | |||||
| 01.06. | ARRAIL GROUP (06639): QUARTERLY UPDATE AND CONTINUED SUSPENSION OF TRADING | - | HKEx | ||
| 10.04. | ARRAIL GROUP (06639): CONNECTED TRANSACTION IN RELATION TO AMENDMENT TO THE LOAN AGREEMENT | - | HKEx | ||
| 09.04. | ARRAIL GROUP (06639): RESUMPTION GUIDANCE AND CONTINUED SUSPENSION OF TRADING | 1 | HKEx | ||
| 02.03. | ARRAIL GROUP (06639): QUARTERLY UPDATE AND CONTINUED SUSPENSION OF TRADING | - | HKEx | ||
| 21.01. | ARRAIL GROUP (06639): (1) SUPPLEMENTAL ANNOUNCEMENT ON DELAY IN PUBLICATION OF THE INTERIM RESULTS AND DELAY IN DESPATCH OF THE 2025 INTERIM REPORT; AND ... | - | HKEx | ||
| 02.12.25 | XFRA I1D: AUSSETZUNG/SUSPENSION | 247 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME Waehrung/Currency ISIN BIS/UNTIL
ARRAIL... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 72,48 | +0,30 % | Pacemaker manufacturer Medtronic warns patients cybercrooks may have swiped health data | ||
| HCA HEALTHCARE | 366,90 | +0,30 % | HCA Healthcare Earnings Preview: What to Expect | ||
| LANTHEUS | 98,20 | +0,51 % | FDA Manufacturing Issues Delay Lantheus' Tumor Imaging Kit | ||
| ENVISTA | 23,800 | +2,59 % | Envista Holdings Corporation: Envista Reports First Quarter 2026 Results | BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
"We delivered a good start... ► Artikel lesen | |
| CAREDX | 25,200 | -1,56 % | Eurobio Scientific finalizes the acquisition of CareDX's transplant Lab Product division | EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX's TRANSPLANT LAB PRODUCT DIVISION Acceleration of Eurobio's strategic plan to become an in-vitro molecular diagnostics ("IVD") leaderCreation... ► Artikel lesen | |
| GT BIOPHARMA | 0,469 | -0,61 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Third Quarter Fiscal Year 2026 Results | Reports 8.5% Increase in ARR to $22.1 Million, Net Income of $860,000 and 14% Year-over-Year Growth in Adjusted EBITDA
HENDERSON, Nev., May 14, 2026 /PRNewswire/... ► Artikel lesen | |
| CARMAT | 0,049 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2026.ISIN NameCA4013392051 GUARDIAN... ► Artikel lesen | |
| CHEMOMETEC | 54,20 | 0,00 % | Chemometec A/S: Growth in revenue and operating profit | Trading statement for Q3 2025/26 (1 January - 31 March 2026) Growth in revenue and operating profit ChemoMetec's revenue was up by 15% in the third quarter of 2025/26 to DKK 142.3 million from DKK... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 5,910 | -22,85 % | Devyser Diagnostics AB: Sales in the second quarter of 2026 weaker than expected | Devyser Diagnostics AB (publ) (the "Company" or the "Group") announces that its preliminary sales for the second quarter of 2026 are weaker than indicated by the information and conditions available... ► Artikel lesen | |
| POLAREAN IMAGING | 0,002 | 0,00 % | Polarean: Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026 | ||
| FRESENIUS | 42,430 | +0,74 % | Fresenius begibt Anleihen im Volumen von 1 Milliarde Euro | DJ Fresenius begibt Anleihen im Volumen von 1 Milliarde Euro
DOW JONES--Der Gesundheitskonzern Fresenius hat Anleihen im Volumen von 1 Milliarde Euro begeben. Die Transaktion umfasst zwei Tranchen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,100 | -0,12 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,970 | +0,03 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,740 | +3,83 % | Warum Carl Zeiss Meditec zum Wochenstart im Fokus erfahrener Anleger steht: Was große Adressen zum Wochenstart bereits wissen - Was ich dieses Wochenende analysiert habe |